欣融國際(01587.HK):預計年度純利同比增長不少於123.50%
格隆匯3月24日丨欣融國際(01587.HK)公佈,截至2021年12月31日止年度股東應占溢利預期將不少於人民幣7800萬元,較截至2020年12月31日止年度的股東應占溢利約人民幣3490萬元增長不少於123.50%。
董事會認為增長主要由於:中國經濟於2021年持續復甦;集團堅定不移地實施其業務模式,成為客户專業及全面的一站式食品原料應用解決方案供應商;集團積極把握髮展機遇,迅速發展,自2021年以來,集團於新成立的中國附屬公司建立了銷售團隊,通過各附屬公司周邊更多、更遠地區的市場滲透,明顯擴大了產品銷售及分銷的地理覆蓋範圍;及公司于田野創新股份有限公司的投資在2021年得到良好回報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.